GSK blood cancer drug nearly halves risk of death in late-stage trial
-
GSK’s multiple myeloma drug Blenrep nearly halved the risk of disease
progression or death compared to standard-of-care treatments for the
incurable bloo...
No posts with label global warming. Show all posts
No posts with label global warming. Show all posts
Subscribe to:
Posts (Atom)